Daniel Jacoby
Yale University
H-index: 42
North America-United States
Top articles of Daniel Jacoby
Methods for treating obstructive hypertrophic cardiomyopathy
2024/4/11
Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4
Journal of Cardiac Failure
2024/3/15
Long-term Safety And Tolerability Of Acoramidis (AG10) In Symptomatic Transthyretin Amyloid Cardiomyopathy: 4-year Update From An Ongoing, Phase 2, Open-label Extension Study
Journal of Cardiac Failure
2024/1/1
Daniel Jacoby
H-Index: 25
Jing Du
H-Index: 13
Characteristics And Procedural Complications Of Septal Myectomy For Obstructive Hypertrophic Cardiomyopathy In The United States
Journal of Cardiac Failure
2024/1/1
Cardiovascular Hospitalizationspost Septal Myectomy For Obstructive Hypertrophic Cardiomyopathy: A 3-year Analysis Of 5,101 Patients
Journal of Cardiac Failure
2024/1/1
Baseline Characteristics of Patients in SEQUOIA-HCM: A Phase 3 Trial of Aficamten in Obstructive Hypertrophic Cardiomyopathy
Journal of Cardiac Failure
2024/1/1
Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy: SEQUOIA-HCM Baseline Characteristics and Study Design
2024/1/1
Aficamten for drug-refractory severe obstructive hypertrophic cardiomyopathy in patients receiving disopyramide: REDWOOD-HCM Cohort 3
Journal of cardiac failure
2023/11
Correlates of cognition among people with chronic heart failure and insomnia
Sleep and Breathing
2023/8
Sangchoon Jeon
H-Index: 27
Daniel Jacoby
H-Index: 25
Efficacy And Safety Of Aficamten In Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From The Randomized Evaluation Of Dosing With Ck-3773274 …
Journal of Cardiac Failure
2023/4/1
Daniel Jacoby
H-Index: 25
Sara Saberi
H-Index: 12
Symptom cluster profiles among adults with insomnia and heart failure
Behavioral Sleep Medicine
2023/3/4
Sangchoon Jeon
H-Index: 27
Daniel Jacoby
H-Index: 25
Effect of beta‐blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy
European Journal of Heart Failure
2023/2
Healthcare Resource Utilization and Economic Burden Due to Atrial Fibrillation in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: Real-World Analysis of 2016 …
Circulation
2023/11/7
Long term outcome after septal reduction therapies in patients with hypertrophic cardiomyopathy: insights from the SHaRe registry
European Heart Journal
2023/11
The effect of mavacamten on cardiopulmonary exercise testing performance of patients with obstructive hypertrophic cardiomyopathy in EXPLORER-HCM
Journal of the American College of Cardiology
2022/3/8
RACIAL DISPARITIES IN UNEXPLAINED LEFT VENTRICULAR HYPERTROPHY
Journal of the American College of Cardiology
2022/3/8
Daniel Jacoby
H-Index: 25
Variability in blood pressure assessment in patients supported with the HeartMate 3TM
ASAIO Journal
2022/3/1
Daniel Jacoby
H-Index: 25
Sex disaggregated analysis of risk factors for adverse outcomes in hypertrophic cardiomyopathy
Heart, Lung and Circulation
2022/1/1
Cognitive behavioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the HeartSleep Study
Sleep
2022/1/1
Pediatric Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
Circulation
2022/11/8
Co-Authors
